DAVIDE CAMPARI-MILANO NV (CPR.MI) Stock Fundamental Analysis
BIT:CPR - Euronext Milan - NL0015435975 - Common Stock - Currency: EUR
CPR gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 26 industry peers in the Beverages industry. Both the profitability and the financial health of CPR get a neutral evaluation. Nothing too spectacular is happening here. CPR is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year CPR was profitable.
In the past year CPR had a positive cash flow from operations.
Each year in the past 5 years CPR has been profitable.
CPR had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of 2.38%, CPR is doing worse than 61.54% of the companies in the same industry.
CPR's Return On Equity of 5.23% is on the low side compared to the rest of the industry. CPR is outperformed by 65.38% of its industry peers.
CPR has a Return On Invested Capital (6.63%) which is comparable to the rest of the industry.
The Average Return On Invested Capital over the past 3 years for CPR is in line with the industry average of 8.31%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.38% | ||
| ROE | 5.23% | ||
| ROIC | 6.63% |
ROA(3y)4.29%
ROA(5y)4.52%
ROE(3y)9.66%
ROE(5y)10.08%
ROIC(3y)7.66%
ROIC(5y)7.27%
1.3 Margins
CPR's Profit Margin of 6.57% is in line compared to the rest of the industry. CPR outperforms 42.31% of its industry peers.
In the last couple of years the Profit Margin of CPR has declined.
Looking at the Operating Margin, with a value of 21.32%, CPR is in the better half of the industry, outperforming 61.54% of the companies in the same industry.
CPR's Operating Margin has been stable in the last couple of years.
The Gross Margin of CPR (57.55%) is better than 69.23% of its industry peers.
In the last couple of years the Gross Margin of CPR has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 21.32% | ||
| PM (TTM) | 6.57% | ||
| GM | 57.55% |
OM growth 3Y3.05%
OM growth 5Y-0.43%
PM growth 3Y-20.58%
PM growth 5Y-17.07%
GM growth 3Y-1.21%
GM growth 5Y-1.11%
2. Health
2.1 Basic Checks
CPR has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for CPR has been increased compared to 1 year ago.
CPR has more shares outstanding than it did 5 years ago.
The debt/assets ratio for CPR has remained at the same level compared to a year ago.
2.2 Solvency
An Altman-Z score of 2.55 indicates that CPR is not a great score, but indicates only limited risk for bankruptcy at the moment.
With a decent Altman-Z score value of 2.55, CPR is doing good in the industry, outperforming 69.23% of the companies in the same industry.
CPR has a debt to FCF ratio of 13.61. This is a negative value and a sign of low solvency as CPR would need 13.61 years to pay back of all of its debts.
CPR has a Debt to FCF ratio of 13.61. This is in the lower half of the industry: CPR underperforms 61.54% of its industry peers.
CPR has a Debt/Equity ratio of 0.66. This is a neutral value indicating CPR is somewhat dependend on debt financing.
CPR has a Debt to Equity ratio of 0.66. This is in the better half of the industry: CPR outperforms 65.38% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.66 | ||
| Debt/FCF | 13.61 | ||
| Altman-Z | 2.55 |
ROIC/WACC0.97
WACC6.84%
2.3 Liquidity
CPR has a Current Ratio of 2.37. This indicates that CPR is financially healthy and has no problem in meeting its short term obligations.
CPR's Current ratio of 2.37 is amongst the best of the industry. CPR outperforms 80.77% of its industry peers.
CPR has a Quick Ratio of 2.37. This is a bad value and indicates that CPR is not financially healthy enough and could expect problems in meeting its short term obligations.
CPR's Quick ratio of 0.99 is amongst the best of the industry. CPR outperforms 88.46% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.37 | ||
| Quick Ratio | 0.99 |
3. Growth
3.1 Past
The earnings per share for CPR have decreased strongly by -40.50% in the last year.
Measured over the past years, CPR shows a decrease in Earnings Per Share. The EPS has been decreasing by -8.12% on average per year.
The Revenue has been growing slightly by 5.18% in the past year.
Measured over the past years, CPR shows a quite strong growth in Revenue. The Revenue has been growing by 10.75% on average per year.
EPS 1Y (TTM)-40.5%
EPS 3Y-11.44%
EPS 5Y-8.12%
EPS Q2Q%N/A
Revenue 1Y (TTM)5.18%
Revenue growth 3Y12.21%
Revenue growth 5Y10.75%
Sales Q2Q%N/A
3.2 Future
The Earnings Per Share is expected to grow by 9.99% on average over the next years. This is quite good.
CPR is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.57% yearly.
EPS Next Y1.31%
EPS Next 2Y6.65%
EPS Next 3Y8.05%
EPS Next 5Y9.99%
Revenue Next Year2.82%
Revenue Next 2Y3.46%
Revenue Next 3Y4.34%
Revenue Next 5Y5.57%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 39.00 indicates a quite expensive valuation of CPR.
Compared to the rest of the industry, the Price/Earnings ratio of CPR indicates a slightly more expensive valuation: CPR is more expensive than 76.92% of the companies listed in the same industry.
CPR is valuated rather expensively when we compare the Price/Earnings ratio to 26.48, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 19.63, the valuation of CPR can be described as rather expensive.
Based on the Price/Forward Earnings ratio, CPR is valued a bit more expensive than 61.54% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 34.04. CPR is valued slightly cheaper when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 39 | ||
| Fwd PE | 19.63 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, CPR is valued a bit more expensive than 65.38% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, CPR is valued a bit more expensive than the industry average as 65.38% of the companies are valued more cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 38.8 | ||
| EV/EBITDA | 14.03 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates CPR does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)29.78
PEG (5Y)N/A
EPS Next 2Y6.65%
EPS Next 3Y8.05%
5. Dividend
5.1 Amount
With a yearly dividend of 0.98%, CPR is not a good candidate for dividend investing.
With a Dividend Yield of 0.98, CPR pays less dividend than the industry average, which is at 2.81. 80.77% of the companies listed in the same industry pay a better dividend than CPR!
With a Dividend Yield of 0.98, CPR pays less dividend than the S&P500 average, which is at 2.39.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.98% |
5.2 History
The dividend of CPR decreases each year by -2.80%.
Dividend Growth(5Y)-2.8%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
38.74% of the earnings are spent on dividend by CPR. This is a low number and sustainable payout ratio.
DP38.74%
EPS Next 2Y6.65%
EPS Next 3Y8.05%
BIT:CPR (8/8/2025, 7:00:00 PM)
6.63
+0.02 (+0.24%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryBeverages
Earnings (Last)
Earnings (Next)
Inst Owners21.06%
Inst Owner ChangeN/A
Ins Owners52%
Ins Owner ChangeN/A
Market Cap8.16B
Analysts70.4
Price Target7.03 (6.03%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.98% |
Yearly Dividend0.04
Dividend Growth(5Y)-2.8%
DP38.74%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.79%
PT rev (3m)-4.24%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-2.21%
Revenue NY rev (3m)-2.52%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 39 | ||
| Fwd PE | 19.63 | ||
| P/S | 2.66 | ||
| P/FCF | 38.8 | ||
| P/OCF | 12.17 | ||
| P/B | 2.12 | ||
| P/tB | 179.02 | ||
| EV/EBITDA | 14.03 |
EPS(TTM)0.17
EY2.56%
EPS(NY)0.34
Fwd EY5.09%
FCF(TTM)0.17
FCFY2.58%
OCF(TTM)0.54
OCFY8.21%
SpS2.49
BVpS3.13
TBVpS0.04
PEG (NY)29.78
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.38% | ||
| ROE | 5.23% | ||
| ROCE | 9.04% | ||
| ROIC | 6.63% | ||
| ROICexc | 6.65% | ||
| ROICexgc | 14.09% | ||
| OM | 21.32% | ||
| PM (TTM) | 6.57% | ||
| GM | 57.55% | ||
| FCFM | 6.85% |
ROA(3y)4.29%
ROA(5y)4.52%
ROE(3y)9.66%
ROE(5y)10.08%
ROIC(3y)7.66%
ROIC(5y)7.27%
ROICexc(3y)8.52%
ROICexc(5y)8.34%
ROICexgc(3y)23.37%
ROICexgc(5y)25.9%
ROCE(3y)10.45%
ROCE(5y)9.91%
ROICexcg growth 3Y-20.45%
ROICexcg growth 5Y-21.73%
ROICexc growth 3Y-7.67%
ROICexc growth 5Y-5.91%
OM growth 3Y3.05%
OM growth 5Y-0.43%
PM growth 3Y-20.58%
PM growth 5Y-17.07%
GM growth 3Y-1.21%
GM growth 5Y-1.11%
F-Score4
Asset Turnover0.36
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.66 | ||
| Debt/FCF | 13.61 | ||
| Debt/EBITDA | 3.27 | ||
| Cap/Depr | 360.3% | ||
| Cap/Sales | 14.99% | ||
| Interest Coverage | 6.99 | ||
| Cash Conversion | 85.71% | ||
| Profit Quality | 104.37% | ||
| Current Ratio | 2.37 | ||
| Quick Ratio | 0.99 | ||
| Altman-Z | 2.55 |
F-Score4
WACC6.84%
ROIC/WACC0.97
Cap/Depr(3y)346.34%
Cap/Depr(5y)266.11%
Cap/Sales(3y)12.99%
Cap/Sales(5y)10.09%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-40.5%
EPS 3Y-11.44%
EPS 5Y-8.12%
EPS Q2Q%N/A
EPS Next Y1.31%
EPS Next 2Y6.65%
EPS Next 3Y8.05%
EPS Next 5Y9.99%
Revenue 1Y (TTM)5.18%
Revenue growth 3Y12.21%
Revenue growth 5Y10.75%
Sales Q2Q%N/A
Revenue Next Year2.82%
Revenue Next 2Y3.46%
Revenue Next 3Y4.34%
Revenue Next 5Y5.57%
EBIT growth 1Y6.42%
EBIT growth 3Y15.63%
EBIT growth 5Y10.27%
EBIT Next Year23.05%
EBIT Next 3Y13.08%
EBIT Next 5Y11.08%
FCF growth 1Y232.49%
FCF growth 3Y-14.61%
FCF growth 5Y-4.94%
OCF growth 1Y328.44%
OCF growth 3Y11.5%
OCF growth 5Y13.06%